固本生血丸治疗慢性再生障碍性贫血的临床与药理研究

吴葆德1; 周长发2; 姚夕珍3; 王云珍3; 张全英4; 李智军4

您当前的位置：

首页 >

文章列表页 >

固本生血丸治疗慢性再生障碍性贫血的临床与药理研究

更新时间：2024-01-04

- 固本生血丸治疗慢性再生障碍性贫血的临床与药理研究
- Clinical and Pharmacological Studies the Treatment of Chronic Aplastic Anemia with“Guben Shengxue Wan”
- 中国实验方剂学杂志 1996年2卷第5期页码：31-34
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R286
- 纸质出版日期：1996
- 稿件说明：
移动端阅览
吴葆德1, 周长发2, 姚夕珍3, 等. 固本生血丸治疗慢性再生障碍性贫血的临床与药理研究[J]. 中国实验方剂学杂志, 1996,2(5):31-34.

Wu Baode, Zhou Changfa, Yao Xizhen, et al. Clinical and Pharmacological Studies the Treatment of Chronic Aplastic Anemia with“Guben Shengxue Wan”[J]. Chinese journal of experimental traditional medical formulae, 1996, 2(5): 31-34.
吴葆德1, 周长发2, 姚夕珍3, 等. 固本生血丸治疗慢性再生障碍性贫血的临床与药理研究[J]. 中国实验方剂学杂志, 1996,2(5):31-34. DOI：

Wu Baode, Zhou Changfa, Yao Xizhen, et al. Clinical and Pharmacological Studies the Treatment of Chronic Aplastic Anemia with“Guben Shengxue Wan”[J]. Chinese journal of experimental traditional medical formulae, 1996, 2(5): 31-34. DOI：

摘要

用中药制剂固本生血丸加康力龙等西药治疗慢性再生障碍性贫血30例

与单用康力龙等西药组进行对照、疗效明显优于对照组

2组同时进行抗马利兰诱发小鼠骨髓造血障碍作用试验

治疗组在降低死亡率及降低骨髓造血障碍发生率方面明显优于对照组。

Abstract

Thirty patients with chronic aplastic anemia were treated with the prescription of Chinese medicines

" Guben Shengxue Wan" in combination with stanozolol.The curative effect was superior to that of the patients treated with stanozolol alone. The experiment of anti-myleran-induced hematopoietic disorder of bone marrow was carried out simultaneously in the two patient groups. The result of the former patient group was superior in decreasing mortality and lowering incidence of hematopoietic disorder to that of the latter.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

补肾生血方治疗慢性再生障碍性贫血的临床疗效及对T细胞亚群、T-bet与GATA3表达的影响

补髓生血汤对慢性再生障碍性贫血患者骨髓基质细胞相关细胞因子的影响

滋髓生血胶囊治疗慢性再生障碍性贫血